OMNIJECT Trademark

Trademark Overview


On Friday, December 2, 2022, a trademark application was filed for OMNIJECT with the United States Patent and Trademark Office. The USPTO has given the OMNIJECT trademark a serial number of 97701905. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, June 19, 2024. This trademark is owned by Alerje, Inc.. The OMNIJECT trademark is filed in the Pharmaceutical Products category with the following description:

Pre-filled autoinjector device sold filled with epinephrine; pre-filled autoinjector device sold filled with insulin; pre-filled autoinjector device sold filled with pharmaceutical preparations, namely, inferons for use in the treatment of cancer and viral infections; pre-filled autoinjector device sold filled with pharmaceutical preparations for use in treating multiple sclerosis; pre-filled autoinjector device sold filled with pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders; pre-filled autoinjector device sold filled with pharmaceutical preparations for treating human immune diseases and conditions; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations for use in stimulating red blood cell production; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations, namely, erythropoiesis stimulating protein
omniject

General Information


Serial Number97701905
Word MarkOMNIJECT
Filing DateFriday, December 2, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, June 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesPre-filled autoinjector device sold filled with epinephrine; pre-filled autoinjector device sold filled with insulin; pre-filled autoinjector device sold filled with pharmaceutical preparations, namely, inferons for use in the treatment of cancer and viral infections; pre-filled autoinjector device sold filled with pharmaceutical preparations for use in treating multiple sclerosis; pre-filled autoinjector device sold filled with pharmaceutical preparations for the treatment of inflammatory and immunological diseases and disorders; pre-filled autoinjector device sold filled with pharmaceutical preparations for treating human immune diseases and conditions; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations for use in stimulating red blood cell production; pre-filled autoinjector device sold filled with prescription pharmaceutical preparations, namely, erythropoiesis stimulating protein

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlerje, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDetroit, MI 48202

Party NameAlerje, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDetroit, MI 48202

Trademark Events


Event DateEvent Description
Tuesday, December 6, 2022NEW APPLICATION ENTERED
Thursday, December 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 11, 2023ASSIGNED TO EXAMINER
Monday, September 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 19, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2024SOU EXTENSION 1 FILED
Wednesday, June 19, 2024SOU EXTENSION 1 GRANTED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT